Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a structured nursing program boost quality of life in advanced lung cancer?

NCT ID NCT07679165

Symptom relief Sponsor: Jie Zeng Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This trial investigates whether an 8-week systematic symptom management nursing program can improve quality of life, self-management skills, and psychological resilience in people with advanced (stage IIIB–IV) lung cancer. Participants are randomly assigned to receive either routine care or the structured program. The study measures changes in quality of life, self-management efficacy, and other outcomes using validated questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
standardized systematic symptom management nursing intervention
What this could lead to
If effective, this nursing program could become a standard way to help advanced lung cancer patients feel better and manage their own care more confidently.
What could go wrong
This is a single-center study with a modest sample size, so results may not apply broadly. The intervention is behavioral, so benefits may vary from person to person.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

176 people

The number who actually took part.

Started

Jun 2023

Finished

Dec 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * According to the diagnostic criteria of primary lung cancer \[9\], the clinical stage was stage ⅢB-Ⅳ * aged 18-75 years old * Karnofsky performance status (KPS) ≥60 and expected survival ≥3 months * Patients had clear consciousness and normal cognitive function, and could complete the questionnaire independently or with the assistance of the researcher * have basic communication skills and can cooperate to complete the whole intervention * Patients or their families informed and signed the consent form. Exclusion Criteria: * primary malignant tumors in other parts * history of severe heart, liver, kidney and other important organ failure, severe infection or mental illness * Unable to cooperate with the study due to cognitive impairment, visual and hearing impairment * participating in other similar nursing intervention studies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Late stage lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Late stage lung cancer Mediating effect Psychological resilience QOL Self management efficacy Symptom managemen

Contacts and locations

Locations

  • Dahua Hospital, Xuhui District, Shanghai

    Shanghai, Shanghai Municipality, 200031, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.